Related to this topic: Equipment | Books | Your Experience | Other resources | Glossaries
Print options:
Other options:
(what's this?)
PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.
Microalbuminuria
Microalbuminuria is defined as excretion of between 30 and 300mg of albumin a day in the urine.
- Less than 30 mg is insignificant.
- Over 300 mg is albuminuria or macroalbuminuria.
Albumin levels below 300mg a day are not detectable by standard dipstick testing, so any positive result is more severe than "microalbuminuria".
Patients with type 2 Diabetes may have microalbuminuria at presentation as they may have had latent disease for years.
This is not usual in type 1 Diabetes. Hence it is recommended that annual screening for microalbuminuria should start at diagnosis in type 2 but only after 5 years in type 1.1
Risk Factors Diabetes and hypertension are both risk factors but together the risk is very high.
Other causes of albuminuria include:
- Glomerulonephritis.
- Amyloidosis.
- Other forms of nephropathy.
All pass through a brief phase of microalbuminuria, but this is short and the diagnosis is usually made with a more substantial proteinuria.
- An early morning urine specimen is more convenient than a 24 hours collection.
- The upper limit of normal is regarded as a urine albumin:creatinine ration of 2.5mg/mmol in men and 3.5mg/mmol in women.
- Some laboratories set a limit of 20mg albumin per litre.
- A positive result should be repeated once or twice in the next month and if it is borderline a full 24 hours urine collection will give a more definitive result.
- Levels below 300mg a day are not detectable by conventional dipstick testing but there are now some sticks for microalbuminuria available on the market.
- False positive results can occur after heavy exercise or with UTI.
- If a diabetic develops heavy proteinuria, especially in a fairly short space of time, then another cause should be sought.
- The same is true if there is no retinopathy.
- If blood creatinine rises above 150 μmol/l referral to a nephrologist is recommended.
|
Management in Diabetes Mellitus The three pillars of management are:
|
| In type 1 diabetes microalbuminuria is a prognostic indicator of renal failure but in type 2 diabetes it is a prognostic indicator of ischaemic heart disease. |
Microalbuminuria is a powerful predictor of increased mortality.6
The process can be reversed by controlling blood pressure, especially with ACE inhibitors. Glycaemic control is not quite so vital. Stopping smoking is imperative.
Intensive management of blood pressure and glycaemia in both type 1 and type 2 diabetes has been shown in the DCCT and UKPDS to improve outcome 7
For the best outcome for heart and kidneys a combination of blood pressure control, use of ACE inhibitors, statins and aspirin are required.8
Document References
- NICE Guidelines; Management of type 2 diabetes - renal disease, prevention and early management (Guideline F), NICE (2002)
- Wade VL, Gleason BL; Dual blockade of the renin-angiotensin system in diabetic nephropathy.; Ann Pharmacother. 2004 Jul-Aug;38(7-8):1278-82. Epub 2004 Jun 8. [abstract]
- Chuahirun T, Simoni J, Hudson C, et al; Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes.; Am J Med Sci. 2004 Feb;327(2):57-67. [abstract]
- Sleight P; The HOPE Study (Heart Outcomes Prevention Evaluation).; J Renin Angiotensin Aldosterone Syst. 2000 Mar;1(1):18-20. [abstract]
- Dykeman-Sharpe J; Proteinuria, a modifiable risk factor: angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs).; CANNT J. 2003 Oct-Dec;13(4):34-6; quiz 37-8. [abstract]
- Allen KV, Walker JD; Microalbuminuria and mortality in long-duration type 1 diabetes.; Diabetes Care. 2003 Aug;26(8):2389-91. [abstract]
- No authors listed; Intensive diabetes management: implications of the DCCT and UKPDS.; Diabetes Educ. 2002 Sep-Oct;28(5):735-40.
- Deferrari G, Ravera M, Berruti V, et al; Optimizing therapy in the diabetic patient with renal disease: antihypertensive treatment.; J Am Soc Nephrol. 2004 Jan;15 Suppl 1:S6-S11. [abstract]
Internet and Further Reading
- NSF for Diabetes
DocID: 365
Document Version: 20
DocRef: bgp2115
Last Updated: 25 Jan 2007
Review Date: 24 Jan 2009
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.
Related pages in Patient UK
Your Experience (^ top of page)
Please add your experience about this condition / medicineOther - Useful resources (^ top of page)
Pictures, diagrams, photos, images, etc.Evidence based medicine
Online textbooks and journals
A-Z of UK Guidelines
A-Z of Online Videos
Medline
Other good health sites
Medical equipment products related to this topic (^ top of page)

Books related to this topic (^ top of page)

Want to search some more? Use the Google Search box below to search our site.

Would you like to try our advanced on-line knowledge support system designed to provide professionals with relevant up to date information about recognition and management of disease or take the Mentor Challenge?
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.
